Diagnosing and managing diabetes in HIV-infected patients: current concepts

Monroe, A. K.; Glesby, M. J.; Brown, T. T.

doi:10.1093/cid/ciu779

Cited by 125HIV-related health complications and treatmentsDiabetes, Cardiovascular Risks, and LipoproteinsHIV/AIDS Research and Interventions

Diagnosing and managing diabetes in HIV-infected patients: current concepts

Monroe, A. K., Glesby, M. J., Brown, T. T.·2015·Clinical Infectious Diseases

DOI 10.1093/cid/ciu779

Open this paper in CoChat — free account

Abstract

Diabetes mellitus (DM) is a common condition with significant associated morbidity and mortality. DM diagnosis and management among human immunodeficiency virus (HIV)-infected patients is a particularly relevant topic as the HIV-infected population ages and more HIV-infected individuals live with chronic medical comorbidities. Although there is mixed evidence regarding HIV as an independent risk factor for DM, multiple factors related to HIV and its treatment are associated with DM. This review covers the epidemiology of DM in HIV-infected patients, and diagnosis, management, and treatment goals for DM in HIV-infected patients. We highlight the most recent DM treatment guidelines from the American Diabetes Association and the European Association for the Study of Diabetes, emphasizing individualization of DM medication therapy and treatment goals. Finally, we review a comprehensive approach to cardiovascular disease risk reduction in HIV-infected patients with DM and measures to prevent other complications of DM.

Integrity signals

Registry

Crossref · 10.1093/cid/ciu779

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

New-onset diabetes is estimated to occur in more than 5% of individuals infected with HIV on PIs, whereas more than 15% may have prediabetes.
“New-onset diabetes is estimated to occur in more than 5% of individuals infected with HIV on PIs, whereas more than 15% may have prediabetes (104).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [104]
New-onset diabetes is estimated to occur in more than 5% of individuals infected with HIV on PIs, whereas more than 15% may have prediabetes.
“New-onset diabetes is estimated to occur in more than 5% of individuals infected with HIV on PIs, whereas more than 15% may have prediabetes (107).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [107]

Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,672 · see citing works
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950 · see citing works
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · see citing works
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · see citing works
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · see citing works
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081 · see citing works
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,197 · see citing works
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572 · see citing works
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919 · see citing works
The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896 · see citing works
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845 · see citing works
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,489 · cited 1× · see citing works
“Comprehensive interventions have been shown to have a significant impact on CVD among patients with DM [71] and should include:”
Background
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470 · see citing works
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735 · cited 1× · see citing works
“duced-calorie intake diet as part of a comprehensive lifestyle modification intervention [38].”
Background
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502 · see citing works
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436 · see citing works
Using Pedometers to Increase Physical Activity and Improve Health: A Systematic Review
Bravata, D. M., Smith-Spangler, C., Sundaram, V., Gienger, A. L., Lin, N., Lewis, R., Stave, C. D., Olkin, I., & Sirard, J. R. (2007) · JAMA · doi:10.1001/jama.298.19.2296 · Cited by 2,064 · see citing works
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613 · see citing works
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522 · see citing works
HIV Infection and the Risk of Acute Myocardial Infarction
Freiberg, M. S., Chang, C.-C. H., Kuller, L. H., Skanderson, M., Lowy, E., Kraemer, K. L., Butt, A. A., Goetz, M. B., Leaf, D. A., Oursler, K. A., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.3728 · Cited by 1,340 · see citing works
Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults: A Scientific Statement From the American Heart Association
Artinian, N. T., Fletcher, G. F., Mozaffarian, D., Kris-Etherton, P., Van Horn, L., Lichtenstein, A. H., Kumanyika, S., Kraus, W. E., Fleg, J. L., Redeker, N. S., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181e8edf1 · Cited by 919 · see citing works
Antiretroviral Therapy and the Prevalence and Incidence of Diabetes Mellitus in the Multicenter AIDS Cohort Study
Brown, T. T. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1179 · Cited by 850 · see citing works
Self-citation
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
Ridker, P. M., Pradhan, A., MacFadyen, J. G., Libby, P., & Glynn, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61190-8 · Cited by 816 · see citing works
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone
Lewis, J. D., Ferrara, A., Peng, T., Hedderson, M., Bilker, W. B., Quesenberry, C. P., Vaughn, D. J., Nessel, L., Selby, J., & Strom, B. L. (2011) · Diabetes Care · doi:10.2337/dc10-1068 · Cited by 625 · see citing works
Population Approaches to Improve Diet, Physical Activity, and Smoking Habits: A Scientific Statement From the American Heart Association
Mozaffarian, D., Afshin, A., Benowitz, N. L., Bittner, V., Daniels, S. R., Franch, H. A., Jacobs, D. R., Kraus, W. E., Kris-Etherton, P. M., Krummel, D. A., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318260a20b · Cited by 601 · cited 1× · see citing works
“Clinicians can recommend several strategies to increase physical activity among their patients [39–43]: an exercise partner, use of a pedometer with a target (eg, 10 000 steps/day), or individualized counseling with exercise prescription.”
Background
[Management of hyperglycaemia in type 2 diabetes: a patient-centered approach].
Scheen, A. J., & Mathieu, C. (2012) · PubMed · Cited by 581 · see citing works
Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P. J., Zingman, B. S., & Horberg, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit665 · Cited by 497 · see citing works
Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients
Wit, S. D., Sabin, C. A., Weber, R. K., Worm, S. W., Reiss, P., Cazanave, C., El-Sadr, W. M., Monforte, A. D., Fontas, É., Law, M. G., et al. (2008) · Diabetes Care · doi:10.2337/dc07-2013 · Cited by 482 · see citing works
The Pros and Cons of Diagnosing Diabetes With A1C
Bonora, E., & Tuomilehto, J. O. (2011) · Diabetes Care · doi:10.2337/dc11-s216 · Cited by 379 · see citing works
Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials
Lamanna, C., Monami, M., Marchionni, N., & Mannucci, E. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01349.x · Cited by 362 · see citing works
Systematic review: glucose control and cardiovascular disease in type 2 diabetes
Kelly, T. N., Bazzano, L. A., Fonseca, V. A., Thethi, T. K., Reynolds, K., & He, J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-6-200909150-00137 · Cited by 358 · see citing works
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial
Neal, B. C., Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Fulcher, G., Stein, P., Desai, M. G., Shaw, W. C., Jiang, J., Vercruysse, F., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.05.007 · Cited by 340 · see citing works
HIV infection and the risk of diabetes mellitus
Butt, A. A., McGinnis, K. A., Rodriguez‐Barradas, M. C., Crystal, S., Simberkoff, M. S., Goetz, M. B., Leaf, D. A., & Justice, A. C. (2009) · AIDS · doi:10.1097/qad.0b013e32832bd7af · Cited by 322 · see citing works
Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study
Ledergerber, B., Furrer, H., Rickenbach, M., Lehmann, R., Elzi, L., Hirschel, B. J., Cavassini, M. L., Bernasconi, E., Schmid, P., Egger, M., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518619 · Cited by 261 · see citing works
Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes
Abraira, C. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.2.181 · Cited by 253 · see citing works
Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy
Brown, T. T., Tassiopoulos, K., Bosch, R. J., Shikuma, C. M., & McComsey, G. A. (2010) · Diabetes Care · doi:10.2337/dc10-0633 · Cited by 236 · see citing works
Self-citation
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment
Capeau, J., Bouteloup, V., Katlama, C., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834e8776 · Cited by 235 · see citing works
Effectiveness of Physical Activity Advice and Prescription by Physicians in Routine Primary Care A Cluster Randomized Trial
Gonzalo Grandes, O. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.23 · Cited by 213 · see citing works
Cardiovascular Events and Correlates in the Veterans Affairs Diabetes Feasibility Trial
Abraira, C. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440230053007 · Cited by 189 · see citing works
Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia
Deeg, M. A., Buse, J. B., Goldberg, R. B., Kendall, D. M., Zagar, A. J., Jacober, S. J., Khan, M. A., Perez, A. T., Tan, M. H., & on behalf of the GLAI Study Investigators (2007) · Diabetes Care · doi:10.2337/dc06-1903 · Cited by 179 · see citing works
Using Pedometers to Increase Physical Activity and Improve Health
Bravata, D. M., Smith-Spangler, C. M., H, V. S. M. P., Gienger, A. L., Stave, C. D., & Sirard, J. R. (2008) · Cited by 172 · see citing works
Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus
Patil, H., Badarin, F. J. A., Shami, H. A. A., Bhatti, S. K., Lavie, C. J., Bell, D. S. H., & O’Keefe, J. H. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.061 · Cited by 159 · see citing works
Prevalence and Pathogenesis of Diabetes Mellitus in HIV-1 Infection Treated With Combined Antiretroviral Therapy
Samaras, K. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31819c291b · Cited by 146 · see citing works
Aspirin Attenuates Platelet Activation and Immune Activation in HIV-1-Infected Subjects on Antiretroviral Therapy
O’Brien, M. P., Montenont, E., Hu, L., Nardi, M. A., Valdes, V., Merolla, M., Gettenberg, G., Cavanagh, K., Aberg, J. A., Bhardwaj, N., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31828a292c · Cited by 146 · see citing works
A1C underestimates glycemia in HIV infection
Kim, P. S., Woods, C., Georgoff, P., Crum, D., Rosenberg, A., Smith, M., & Hadigan, C. (2009) · Diabetes Care · doi:10.2337/dc09-0177 · Cited by 145 · see citing works
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
Home, P., & Lagarenne, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1530-5 · Cited by 141 · see citing works
Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study
Rasmussen, L. D., Mathiesen, E. R., Kronborg, G., Pedersen, C., Gerstoft, J., & Obel, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044575 · Cited by 140 · see citing works
Initiate Insulin by Aggressive Titration and Education (INITIATE)
Yki-Järvinen, H., Juurinen, L., Alvarsson, M., Bystedt, T., Caldwell, I., Davies, M., Lahdenperä, S., Nijpels, G., & Vähätalo, M. (2007) · Diabetes Care · doi:10.2337/dc06-1357 · Cited by 139 · see citing works
Statins, Risk of Diabetes, and Implications on Outcomes in the General Population
Wang, K.-L., Liu, C., Chao, T., Huang, C.-M., Wu, C., Chen, S., Chen, T., Lin, S., & Chiang, C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.019 · Cited by 130 · see citing works
Pioglitazone and cardiovascular risk. A comprehensive meta‐analysis of randomized clinical trials
Mannucci, E., Monami, M., Lamanna, C., Gensini, G., & Marchionni, N. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00892.x · Cited by 103 · see citing works
Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013
Schernthaner, G., Currie, C. J., & Schernthaner, G.-H. (2013) · Diabetes Care · doi:10.2337/dcs13-2031 · Cited by 100 · see citing works
The Effect of HAART and HCV Infection on the Development of Hyperglycemia Among HIV-Infected Persons
Mehta, S. H., Moore, R. D., Thomas, D. L., Chaisson, R. E., & Sulkowski, M. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200308150-00005 · Cited by 95 · see citing works
Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy
Galli, L., Salpietro, S., Pellicciotta, G., Galliani, A., Piatti, P., Hasson, H., Guffanti, M., Gianotti, N., Bigoloni, A., Lazzarin, A., et al. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9707-5 · Cited by 94 · see citing works
Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution
Meininger, G. E., Hadigan, C. M., Laposata, M., et al. (2002) · Metabolism · doi:10.1053/meta.2002.29999 · Cited by 78 · see citing works
Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters
Slama, L., Palella, F. J., Abraham, A. G., Li, X., Vigouroux, C., Pialoux, G., Kingsley, L., Lake, J. E., Brown, T. T., Margolick, J. B., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku295 · Cited by 71 · see citing works
Self-citation
Inappropriately Low Glycated Hemoglobin Values and Hemolysis in HIV-Infected Patients
Diop, M.-E., Bastard, J., Meunier, N., Thévenet, S., Maachi, M., Capeau, J., Pialoux, G., & Vigouroux, C. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.1242 · Cited by 68 · see citing works
Aspirin Resistance: Current Status and Role of Tailored Therapy
Grinstein, J., & Cannon, C. P. (2012) · Clinical Cardiology · doi:10.1002/clc.22031 · Cited by 63 · see citing works
Perceived Individual, Social, and Environmental Factors for Physical Activity and Walking
Granner, M. L., Sharpe, P. A., Hutto, B., Wilcox, S., & Addy, C. L. (2007) · Journal of Physical Activity and Health · doi:10.1123/jpah.4.3.278 · Cited by 52 · see citing works
Molecular mechanisms for insulin resistance in treated HIV-infection
Hruz, P. W. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.017 · Cited by 51 · see citing works
Glycated Haemoglobin in Diabetic Women with and without HIV Infection: Data from the Women's Interagency HIV Study
Glesby, M. J., Hoover, D. R., Shi, Q., Danoff, A., Howard, A. A., Tien, P. C., Merenstein, D., Cohen, M. H., Golub, E. T., DeHovitz, J. A., et al. (2009) · Antiviral Therapy · doi:10.3851/imp1557 · Cited by 46 · see citing works
Self-citation
Inaccurate Glycosylated Hemoglobin A1C Measurements in Human Immunodeficiency Virus—Positive Patients with Diabetes Mellitus
Polgreen, P. M., Putz, D., & Stapleton, J. T. (2003) · Clinical Infectious Diseases · doi:10.1086/376633 · Cited by 46 · see citing works
Dipeptidyl Peptidase IV Inhibition Does Not Adversely Affect Immune or Virological Status in HIV Infected Men And Women: A Pilot Safety Study
Goodwin, S. R., Reeds, D. N., Royal, M., Struthers, H., Laciny, E., & Yarasheski, K. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3532 · Cited by 38 · see citing works
Impact of randomized antiretroviral therapy initiation on glucose metabolism
Erlandson, K. M., Kitch, D. W., Tierney, C., Sax, P. E., Daar, E. S., Melbourne, K. M., Ha, B., & McComsey, G. A. (2014) · AIDS · doi:10.1097/qad.0000000000000266 · Cited by 36 · see citing works
Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study
Lichtenstein, K. A., Hart, R. L. D., Wood, K. C., Bozzette, S. A., Buchacz, K. A., & Brooks, J. T. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000581 · Cited by 35 · see citing works
The Effects of Opiate Use and Hepatitis C Virus Infection on Risk of Diabetes Mellitus in the Women's Interagency HIV Study
Howard, A. A., Hoover, D. R., Anastos, K., Wu, X., Shi, Q., Strickler, H. D., Cole, S. R., Cohen, M. H., Kovács, A., Augenbraun, M. H., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181d0c911 · Cited by 34 · see citing works
Sex Hormones, Insulin Resistance, and Diabetes Mellitus Among Men With or at Risk for HIV Infection
Monroe, A. K., Dobs, A. S., Xu, X., Palella, F. J., Kingsley, L., Witt, M. D., & Brown, T. T. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182278c09 · Cited by 33 · see citing works
Self-citation
Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimens
Tungsiripat, M., El‐Bejjani, D., Rizk, N., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328339e274 · Cited by 28 · see citing works
Incident Hyperglycaemia among Older Adults with or At-Risk for HIV Infection
Polsky, S., Floris-Moore, M., Schoenbaum, E. E., Klein, R. S., Arnsten, J. H., & Howard, A. A. (2010) · Antiviral Therapy · doi:10.3851/imp1711 · Cited by 26 · see citing works
Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Trial
Esposito, K., Maiorino, M. I., Ciotola, M., Di Palo, C., Scognamiglio, P., Gicchino, M., Petrizzo, M., Saccomanno, F., Beneduce, F., Ceriello, A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-5-200909010-00004 · Cited by 13 · see citing works

Flagged first, then by citations

Sorted by citations

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792 · see citing works
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116 · see citing works
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086 · see citing works
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393 · see citing works

Authors: Monroe, A. K., Glesby, M. J., & Brown, T. T.
Affiliations: Johns Hopkins University (US)
Weill Cornell Medicine (US)
ORCID: Monroe, A. K.
Glesby, M. J.
Brown, T. T.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2014-10-13
Volume: 60
Issue: 3
Pages: 453-462
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1093/cid/ciu779
OpenAlex: W2086163170
Cited by: 125
References: 69
Citations by year: 2026: 2 · 2025: 10 · 2024: 13 · 2023: 9 · 2022: 16 · 2021: 18 · 2020: 11 · 2019: 12 · 2018: 13 · 2017: 14 · 2016: 7
FWCI: 1.47
Type: journal article
Language: en
Open access: closed
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords: diabetes mellitus, HIV infection, diabetes diagnosis, diabetes management, antiretroviral therapy, cardiovascular risk reduction, diabetes complications, comorbidities
MeSH terms: Diabetes Mellitus, Humans, Risk Factors, HIV Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diagnosing and managing diabetes in HIV-infected patients: current concepts

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks